×
About 9,703 results

ALLMedicine™ Bronchitis Center

Research & Reviews  2,215 results

Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 ...
https://doi.org/10.1093/infdis/jiac150
The Journal of Infectious Diseases; Johannesen CK, van Wijhe M et. al.

Jun 25th, 2022 - Knowledge on age-specific hospitalizations associated with RSV infection is limited due to limited testing, especially in older children and adults in whom RSV infections are not expected to be severe. Burden estimates based on RSV coding of hospi...

Estimating the Impact of Air Pollution on Healthcare-Seeking Behaviour by Applying a Di...
https://doi.org/10.3390/ijerph19127097
International Journal of Environmental Research and Publi... Morbey R, Smith G et. al.

Jun 25th, 2022 - Syndromic surveillance data were used to estimate the direct impact of air pollution on healthcare-seeking behaviour, between 1 April 2012 and 31 December 2017. A difference-in-differences approach was used to control for spatial and temporal vari...

Evaluation of the multimorbidity network and its relationship with clinical phenotypes ...
https://doi.org/10.1111/crj.13518
The Clinical Respiratory Journal; Figueira-Gonçalves JM, Golpe R et. al.

Jun 23rd, 2022 - Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous condition, in which taking into consideration clinical phenotypes and multimorbidity is relevant to disease management. Network analysis, a procedure designed to study com...

Long-term Observational Study of the Safety of Roflumilast
https://clinicaltrials.gov/ct2/show/NCT03381573

Jun 23rd, 2022 - Rationale and background Roflumilast is licensed (i) for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis (CB) in adult patients with...

see more →

Guidelines  6 results

ACR Appropriateness Criteria® Chronic Cough.
https://doi.org/10.1016/j.jacr.2021.08.007
Journal of the American College of Radiology : JACR; , Kuzniewski CT et. al.

Nov 20th, 2021 - Chronic cough is defined by a duration lasting at least 8 weeks. The most common causes of chronic cough include smoking-related lung disease, upper airway cough syndrome, asthma, gastroesophageal reflux disease, and nonasthmatic eosinophilic bron...

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Chronic Cough Due to Stable Chronic Bronchitis: CHEST Expert Panel Report.
https://doi.org/10.1016/j.chest.2020.02.015
Chest Malesker MA, Callahan-Lyon P et. al.

Feb 28th, 2020 - Chronic cough due to chronic bronchitis (CB) causes significant impairment in quality of life, and effective treatment strategies are needed. We conducted a systematic review on the management of chronic cough due to CB to update the recommendatio...

Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients: CHEST Expert ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173775
Chest Smith MP, Lown M et. al.

Feb 25th, 2020 - Evidence for the diagnosis and management of cough due to acute bronchitis in immunocompetent adult outpatients was reviewed as an update to the 2006 "Chronic Cough Due to Acute Bronchitis: American College of Chest Physicians (ACCP) Evidence-Base...

Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guidelin...
https://doi.org/10.1016/j.chest.2019.12.021
Chest Côté A, Russell RJ et. al.

Jan 24th, 2020 - Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults. We sought to determine the role of non-invasive measurements of airway inflammation, including induced sputum and fractional exhaled...

see more →

Drugs  813 results see all →

Clinicaltrials.gov  331 results

Long-term Observational Study of the Safety of Roflumilast
https://clinicaltrials.gov/ct2/show/NCT03381573

Jun 23rd, 2022 - Rationale and background Roflumilast is licensed (i) for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis (CB) in adult patients with...

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
https://clinicaltrials.gov/ct2/show/NCT05381454

Jun 22nd, 2022 - Overview of study design Open label clinical trial (intervention with a diet supplement) to evaluate the safety and efficacy of treatment with mitoquinone/mitoquinol mesylate (mito-MES) (20 mg daily) daily to prevent any viral infection in high-ri...

RejuvenAir® System Trial for COPD With Chronic Bronchitis
https://clinicaltrials.gov/ct2/show/NCT03893370

Jun 14th, 2022 - The RejuvenAir® System is a cryosurgical device that applies medical-grade liquid nitrogen to the treatment area via a radial head catheter in a small, accurately directed spray. Cryotherapy with the RejuvenAir® System is designed to induce a rege...

Study of COPD Subgroups and Biomarkers
https://clinicaltrials.gov/ct2/show/NCT01969344

Jun 10th, 2022 - SPIROMICS was initially funded through contracts from the NIH. That phase of SPIROMICS is now referred to as SPIROMICS I. SPIROMICS is now funded as a grant from the NIH. The current phase is referred to as SPIROMICS II. Brief summary of SPIROMICS...

Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
https://clinicaltrials.gov/ct2/show/NCT02315898

Jun 6th, 2022 - Background and Rationale: Plastic bronchitis (PB) is a rare, disease characterized by the formation of obstructive fibrin airway casts. Presently, acute exacerbations of the illness are often treated with inhaled tissue plasminogen activator (tPA)...

see more →

News  485 results

Upadacitinib Recommended for Nonradiographic AxSpA in Europe
https://www.medscape.com/viewarticle/976301

Jun 28th, 2022 - Upadacitinib may soon be used for the treatment of nonradiographic axial spondyloarthritis (nr-axSpA) after the European Medicines Agency's Committee for Medicinal Products for Human Use gave it its stamp of approval last week. AbbVie, the drug's ...

Antibiotic Prescribing Practice Varies Widely in Canada
https://www.medscape.com/viewarticle/973789

May 11th, 2022 - Even before the COVID-19 pandemic, primary care doctors in Canada often prescribed antibiotics unnecessarily for respiratory tract infections such as the common cold, sinusitis, and acute bronchitis, according to new research. For some viral condi...

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Black, Senior Patients More Likely to Get Unneeded Antibiotics
https://www.medscape.com/viewarticle/972492

Apr 20th, 2022 - Black and senior patients are more likely to be overprescribed antibiotics, according to a new study of 7 billion trips to healthcare centers — findings that doctors say warrant a further look into unequal prescription practices. Researchers at th...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

see more →

Patient Education  31 results see all →